Thesis/Theses examined by Gießen-Jung, Clemens

Torlot, Lucien Edward (2023): Proteomics uncover EPHA2 in cetuximab resistant colorectal cancer cell lines as a potential novel therapeutic target. Dissertation, LMU München: Faculty of Medicine

Dullinger, Maximilian Julian (2022): Validierung des Biomarkers Claudin-3 für das peritoneal metastasierte Dickdarmkarzinom. Dissertation, LMU München: Faculty of Medicine

Seckendorff, Leopold (2021): Validation of biomarkers predictive of tumor location in coloadenocarcinoma, an analysis of the TCGA COAD dataset. Dissertation, LMU München: Faculty of Medicine

Schön, Rudolph (2020): Neue Möglichkeiten der FET-PET basierten Bestrahlungsplanung bei Patienten mit Glioblastom in der Primärsituation. Dissertation, LMU München: Faculty of Medicine

Böckle, David (2019): Radio(chemo)therapie beim Ösophaguskarzinom bei älteren Patienten – Retrospektive Analyse unter besonderer Berücksichtigung der Toxizität. Dissertation, LMU München: Faculty of Medicine

Jin, Xifeng (2019): Novel strategies for targeted therapy in NETs: inhibition of Wnt signaling in neuroendocrine tumors and improving peptide receptor chemoradionuclide therapy (PRCRT) by a combination of 5-fluorouracil and epigenetic modifiers. Dissertation, LMU München: Faculty of Medicine

Hagenhoff, Anna Maria (2018): Engineered mesenchymal stem cells In tumor therapy: a comparison of three targeting strategies. Dissertation, LMU München: Faculty of Medicine